Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond.

Domar AD, Moragianni VA, Ryley DA, Urato AC.

Hum Reprod. 2013 Jan;28(1):160-71. doi: 10.1093/humrep/des383. Epub 2012 Oct 31. Review.

PMID:
23117129
2.

Infertility and the risk of adverse pregnancy outcomes: a systematic review and meta-analysis.

Messerlian C, Maclagan L, Basso O.

Hum Reprod. 2013 Jan;28(1):125-37. doi: 10.1093/humrep/des347. Epub 2012 Oct 5. Review.

PMID:
23042798
3.

Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.

Ferreira E, Carceller AM, Agogué C, Martin BZ, St-André M, Francoeur D, Bérard A.

Pediatrics. 2007 Jan;119(1):52-9.

PMID:
17200271
4.

SSRI antidepressants and persistent pulmonary hypertension in newborns.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):156.

PMID:
19492488
5.

Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.

Malm H.

Ther Drug Monit. 2012 Dec;34(6):607-14. doi: 10.1097/FTD.0b013e31826d07ea. Review.

PMID:
23042258
6.

Safety of selective serotonin reuptake inhibitors in pregnancy.

Alwan S, Friedman JM.

CNS Drugs. 2009;23(6):493-509. doi: 10.2165/00023210-200923060-00004. Review.

PMID:
19480468
7.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Eke AC, Saccone G, Berghella V.

BJOG. 2016 Nov;123(12):1900-1907. doi: 10.1111/1471-0528.14144. Epub 2016 May 30. Review.

PMID:
27239775
8.

Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.

El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H.

Arch Gen Psychiatry. 2012 Jul;69(7):706-14. doi: 10.1001/archgenpsychiatry.2011.2333.

PMID:
22393202
9.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
10.

Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Cantor Sackett J, Weller RA, Weller EB.

Curr Psychiatry Rep. 2009 Jun;11(3):253-7. Review.

PMID:
19470288
11.

Fluoxetine during pregnancy: impact on fetal development.

Morrison JL, Riggs KW, Rurak DW.

Reprod Fertil Dev. 2005;17(6):641-50. Review.

PMID:
16263070
12.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

13.

[Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].

Cissoko H, Swortfiguer D, Giraudeau B, Jonville-Béra AP, Autret-Leca E.

Arch Pediatr. 2005 Jul;12(7):1081-4. French.

PMID:
15964522
14.

The effect of perinatal exposures on the infant: antidepressants and depression.

Hanley GE, Oberlander TF.

Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):37-48. doi: 10.1016/j.bpobgyn.2013.09.001. Epub 2013 Sep 18. Review.

PMID:
24100223
15.

[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].

Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.

Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Review. French.

PMID:
20513456
16.

Antidepressants in pregnancy: a systematic review.

Udechuku A, Nguyen T, Hill R, Szego K.

Aust N Z J Psychiatry. 2010 Nov;44(11):978-96. doi: 10.3109/00048674.2010.507543. Review.

PMID:
21034181
17.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
18.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
19.

Neonates born to mothers using antidepressant drugs.

Zuccotti GV, Fabiano V, Manfredini V.

Early Hum Dev. 2012 May;88 Suppl 2:S84-5. doi: 10.1016/S0378-3782(12)70023-3. No abstract available.

PMID:
22633523
20.

SSRI antidepressants and birth defects.

[No authors listed]

Prescrire Int. 2006 Dec;15(86):222-3.

PMID:
17167929

Supplemental Content

Support Center